Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-30

Clinical Trial Update: Study to Assess the Efficacy and Safety of Dysport® in Cervical Dystonia [Phase 3]

View source ↗

Summary

Phase 3 trial update for Dysport in cervical dystonia, completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dysport (abobotulinumtoxinA)

Snippet

Sponsor: Ipsen | Conditions: Cervical Dystonia | Phase 3 | Status: COMPLETED | Results posted: 2018-07-30